# Health Economic Evaluation of Primovist-enhanced Liver MRI

> **NCT00764621** · PHASE4 · COMPLETED · sponsor: **Bayer** · enrollment: 360 (actual)

## Conditions studied

- Colorectal Neoplasms
- Neoplasm Metastasis

## Interventions

- **PROCEDURE:** Primovist MRI
- **PROCEDURE:** Extracellular contrast media (ECCM) MRI
- **PROCEDURE:** Contrast-enhanced CT

## Key facts

- **NCT ID:** NCT00764621
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2010-09
- **Final completion:** 2010-11
- **Target enrollment:** 360 (ACTUAL)
- **Last updated:** 2014-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00764621

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00764621, "Health Economic Evaluation of Primovist-enhanced Liver MRI". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00764621. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*